Corporate Profile
| Company | GeneFrontier Corporation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Established | October 13, 2010 | ||||||||
| Capital | 10 million yen | ||||||||
| Board of Directors |
|
||||||||
| Shareholders | KANEKA Corporation | ||||||||
| Business |
1. Providing innovative research products, services and technologies in protein engineering and drug discovery. 2. Development of Novel Biologics including Therapeutic Monoclonal Antibody. |
||||||||
| Contact | SHARP Kashiwa Building, 4F 273-1 Kashiwa, Kashiwa-shi, Chiba 277-0005, Japan |
||||||||
| Phone Facsimile |
+81-4-7137-6301 +81-4-7132-7530 |
||||||||
| Please contact here |
